CH Biotech R&D Co., Ltd. (TPE:6534)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
110.00
+4.50 (4.27%)
At close: Oct 23, 2025
4.27%
Market Cap11.31B
Revenue (ttm)1.68B
Net Income (ttm)364.31M
Shares Out102.80M
EPS (ttm)3.53
PE Ratio31.18
Forward PEn/a
Dividend4.10 (3.73%)
Ex-Dividend DateAug 21, 2025
Volume132,388
Average Volume64,061
Open104.00
Previous Close105.50
Day's Range104.00 - 110.50
52-Week Range71.10 - 123.50
Beta0.15
RSI52.28
Earnings DateNov 5, 2025

About CH Biotech R&D

CH Biotech R&D Co., Ltd., a biotech company, engages in the research and development of biotech drugs for agrochemical products in Taiwan, the United States, and internationally. The company offers plant growth regulators and fertilizers; and biotechnology services. CH Biotech R&D Co., Ltd. was incorporated in 2013 and is based in Nantou City, Taiwan. [Read more]

Sector Materials
Founded 2013
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6534
Full Company Profile

Financial Performance

In 2024, CH Biotech R&D's revenue was 1.64 billion, an increase of 7.98% compared to the previous year's 1.51 billion. Earnings were 476.39 million, an increase of 2.83%.

Financial Statements

News

There is no news available yet.